Log in

Clinigen Group Stock Price, News & Analysis (OTCMKTS:CLIGF)

$10.70
0.00 (0.00 %)
(As of 10/14/2019)
Add
Compare
Today's Range
$10.70
Now: $10.70▼
$10.70
50-Day Range
$10.70
MA: $12.72▼
$12.90
52-Week Range
$10.70
Now: $10.70▼
$12.90
Volume1,000 shs
Average Volume50 shs
Market Capitalization$1.31 billion
P/E RatioN/A
Dividend YieldN/A
Beta-0.34

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CLIGF
Previous SymbolNASDAQ:CLIGF
CUSIPN/A
CIKN/A
Webhttp://www.clinigengroup.com/
Phone01283 495010

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$595.93 million
Price / Sales2.20
Cash Flow$0.50 per share
Price / Cash Flow21.39
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares122,290,000
Market Cap$1.31 billion
Next Earnings DateN/A
OptionableNot Optionable
OTC:CLIGF Rates by TradingView

Receive CLIGF News and Ratings via Email

Sign-up to receive the latest news and ratings for CLIGF and its competitors with MarketBeat's FREE daily newsletter.


Clinigen Group (OTCMKTS:CLIGF) Frequently Asked Questions

What is Clinigen Group's stock symbol?

Clinigen Group trades on the OTCMKTS under the ticker symbol "CLIGF."

Has Clinigen Group been receiving favorable news coverage?

News articles about CLIGF stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Clinigen Group earned a news impact score of 0.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Clinigen Group.

Who are some of Clinigen Group's key competitors?

What other stocks do shareholders of Clinigen Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Clinigen Group investors own include Kion Group (KGX), Xilinx (XLNX), Dillard's (DDS), Clime Investment Management (CIW), Apollo Investment (AINV), Altaba (AABA), Witan Investment Trust (WTAN), Telford Homes (TEF), SIG (SHI) and Land Securities Group (LAND).

How do I buy shares of Clinigen Group?

Shares of CLIGF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Clinigen Group's stock price today?

One share of CLIGF stock can currently be purchased for approximately $10.70.

How big of a company is Clinigen Group?

Clinigen Group has a market capitalization of $1.31 billion and generates $595.93 million in revenue each year. View Additional Information About Clinigen Group.

What is Clinigen Group's official website?

The official website for Clinigen Group is http://www.clinigengroup.com/.

How can I contact Clinigen Group?

Clinigen Group's mailing address is PITCAIRN HOUSE CROWN SQUARE FIRST AVENUE, STAFFORDSHIRE X0, D E14 2W W. The company can be reached via phone at 01283 495010.


MarketBeat Community Rating for Clinigen Group (OTCMKTS CLIGF)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  72 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  173
MarketBeat's community ratings are surveys of what our community members think about Clinigen Group and other stocks. Vote "Outperform" if you believe CLIGF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLIGF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/20/2019 by MarketBeat.com Staff

Featured Article: Understanding each part of a balance sheet
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel